Ten Drug Companies Plan Joint Research on Key Diseases

Ten of the world's biggest drug companies -- normally the most competitive of rivals -- are joining with U.S. health experts in an unusual new effort to develop treatments for major diseases. The agreement was announced Tuesday in Washington. It calls for the group to spend $230 million over the next five years as researchers look for cures for Alzheimer's disease, type 2 diabetes, and two autoimmune disorders, rheumatoid arthritis and lupus. The drug companies collectively...

© La Voix de l'Amérique - mardi 4 février 2014